Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis

Nitric Oxide - Biology and Chemistry

Volumn 14, Issue 2 SPEC. ISS., 2006, Pages 130-136

  Takahashi, Mami ^a   Mutoh, Michihiro ^a   Shoji, Yutaka ^a   Sato, Hidetaka ^b   Kamanaka, Yoshihisa ^c   Naka, Masao ^c   Maruyama, Takayuki ^c   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JAPAN FOOD RESEARCH LABORATORIES   (Japan)

^c ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Azoxymethane; Colon cancer; iNOS inhibitor; ONO 1714; Rat

Indexed keywords

7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO[4.1.0]HEPTANE; AZOXYMETHANE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; COLON TUMOR; CONTROLLED STUDY; HISTOLOGY; INTESTINE TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ANIMALIA;

EID: 31544447175     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.07.004     Document Type: Article

References (44)

1. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
2. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah NF-κB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466
3. C.J. van der Wounde, J.H. Kleibeuker, P.L.M. Jansen, and H. Moshage Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract Apoptosis 9 2004 123 130
4. H. Maeda, and T. Akaike Nitric oxide and oxygen radicals in infection, inflammation, and cancer Biochemistry 63 1998 854 865
5. P.K. Lala, and C. Chakraborty role of nitric oxide in carcinogenesis and tumour progression Lancet Oncol. 2 2001 149 156
6. H. Ohshima, M. Tatemichi, and T. Sawa Chemical basis of inflammation-induced carcinogenesis Arch. Biochem. Biophys. 417 2003 3 11
7. S. Ambs, W.G. Merriam, W.P. Bennett, E. Felley-Bosco, M.O. Ogunfusika, S.M. Oser, S. Klein, P.G. Shields, T.R. Billiar, and C.C. Harris Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression Cancer Res. 58 1998 334 341
8. A. Rajnakova, P.M.Y. Goh, T.F. Chanm, S.S. Ngoi, A. Alponat, and S. Moochhala Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue Carcinogenesis 18 1997 1841 1845
9. K.T. Wilson, S. Fu, K.S. Ramanujam, and S.J. Meltzer Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas Cancer Res. 58 1998 2929 2934
10. C.-Y. Liu, C.-H. Wang, T.-C. Chen, H.-C. Lin, C.-T. Yu, and H.-P. Kuo Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer Br. J. Cancer 78 1998 534 541
11. S.M. Vickers, L.A. MacMillan-Crow, M. Green, C. Ellis, and J.A. Thompson Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer Arch. Surg. 134 1999 245 251
12. L. Franco, D. Doria, E. Bertazzoni, A. Benini, and C. Bassi Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer Prostaglandins Other Lipid Mediat. 73 2004 51 58
13. H.U. Kasper, H. Wolf, U. Drebber, H.K. Wolf, and M.A. Kern Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density World J. Gastroenterol. 10 2004 1918 1922
14. T. Klotz, W. Bloch, C. Volberg, U. Engelmann, and K. Addicks Selective expression of inducible nitric oxide synthase in human prostate carcinoma Am. Cancer Soc. 82 1998 1897 1903
15. M. Takahashi, K. Fukuda, T. Ohata, T. Sugimura, and K. Wakabayashi Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane Cancer Res. 57 1997 1233 1237
16. M. Takahashi, M. Mutoh, T. Kawamori, T. Sugimura, and K. Wakabayashi Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis Carcinogenesis 21 2000 1319 1327
17. Asp12 cDNA markedly elevates IL-1β and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells Oncogene 22 2003 7667 7676
18. S. Ichii, S. Takeda, A. Horii, S. Nakatsuru, Y. Miyoshi, M. Emi, Y. Fujiwara, K. Koyama, J. Furuyama, J. Utsunomiya, and Y. Nakamura Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP) Oncogene 8 1993 2399 2405
19. ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1 Cancer Res. 60 2000 4602 4609
20. T. Kawamori, M. Takahashi, K. Watanabe, T. Ohta, S. Nakatsugi, T. Sugimura, and K. Wakabayashi Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor Cancer Lett. 148 2000 33 37
21. C.V. Rao, T. Kawamori, R. Hamid, and B.S. Reddy Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor Carcinogenesis 20 1999 641 644
22. C.V. Rao, C. Indranie, B. Simi, R.T. Manning, J.R. Connor, and B.S. Reddy Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor Cancer Res. 62 2002 165 170
23. M. Naka, T. Nanbu, K. Kobayashi, Y. Kamanaka, M. Komeno, R. Yanase, T. Fukutomi, S. Fujimura, H. Seo, N. Fujiwara, S. Ohuchida, K. Suzuki, K. Kondo, and N. Taniguchi A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative Biochem. Biophys. Res. Commun. 270 2000 663 667
24. Y. Hayashi, M. Abe, A. Murai, N. Shimizu, I. Okamoto, T. Katsuragi, and K. Tanaka Comparison of effects of nitric oxide synthase (NOS) inhibitors on plasma nitrite/nitrate levels and tissue NOS activity in septic organs Microbiol. Immunol. 49 2005 139 147
25. R.P. Bird Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings Cancer Lett. 37 1987 147 151
26. M. Takahashi, T. Minamoto, N. Yamashita, K. Yazawa, T. Sugimura, and H. Esumi Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid Cancer Res. 53 1993 2786 2789
27. B.S. Reddy, C.V. Rao, A. Rivenson, and G. Kelloff Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
28. T. Shirai, J. Nakanowatari, Y. Kurata, S. Fukushima, and N. Ito Different dose-response relationships in the induction of different types of colonic tumors in Wistar rats by 1,2-dimethylhydrazine Gann 74 1983 21 27
29. J.M. Ward Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats Lab. Invest. 30 1974 505 513
30. M. Takahashi, M. Fukutake, T. Isoi, K. Fukuda, H. Sato, K. Yazawa, T. Sugimura, and K. Wakabayashi Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA) Carcinogenesis 18 1997 1337 1342
31. B.A. Narayanan, N.K. Narayanan, B. Simi, and B.S. Reddy Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells Cancer Res. 63 2003 972 979
32. O.S. Sohn, E.S. Fiala, S.P. Requeijo, J.H. Weisburger, and F.J. Gonzalez Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol Cancer Res. 61 2001 8435 8440
33. J. Folkman What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82 1990 4 6
34. J. Wu, T. Akaike, K. Hayashida, T. Okamoto, A. Okuyama, and H. Maeda Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases Jpn. J. Cancer Res. 92 2001 439 451
35. D. Salvemini, T.P. Misko, J.L. Masferrer, K. Seibert, M.G. Currie, and P. Needleman Nitric oxide activates cyclooxygenase enzymes Proc. Natl. Acad. Sci. USA 90 1993 7240 7244
36. J.A. Corbett, G. Kwon, J. Turk, and M.L. McDaniel IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide Biochemistry 32 1993 13767 13770
37. D. Salvemini, K. Seibert, J.L. Masferrer, T.P. Misko, M.G. Currie, and P. Needleman Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation J. Clin. Invest. 93 1994 1940 1947
38. F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, I. Sardi, N. Lasagna, F. Perna, V. Fabbroni, A. Di Felice, G. Perigli, R. Mazzanti, and E. Masini Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin. Cancer Res. 10 2004 2694 2704
39. R.J. Bing, M. Miyataka, K.A. Rich, N. Hansin, X. Wang, H.D. Slosser, and S.-R. Shi Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer Clin. Cancer Res. 7 2001 3385 3392
40. M. Ichinoe, T. Mikami, H. Shiraishi, and I. Okayasu High microvascular density is correlated with high VEGF, iNOS and COX-2 expression in penetrating growth-type early gastric carcinomas Histopathology 45 2004 612 618
41. M.R. Raspollini, G. Amunni, A. Villanucci, V. Boddi, G. Baroni, A. Taddei, and G.L. Taddei Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome Gynecol. Oncol. 92 2004 806 812
42. W. Li, R.J. Xu, L.H. Jiang, J. Shi, X. Long, and B. Fan Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma Med. Oncol. 22 2005 63 70
43. A. Hara, and I. Okayasu Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance Acta. Neuropathol. 108 2004 43 48
44. A.A. Adjei Blocking oncogenic Ras signaling for cancer therapy J. Natl. Cancer Inst. 93 2001 1062 1074